165 related articles for article (PubMed ID: 24716727)
1. Butyrate induced changes in Wnt-signaling specific gene expression in colorectal cancer cells.
Lazarova DL; Chiaro C; Bordonaro M
BMC Res Notes; 2014 Apr; 7():226. PubMed ID: 24716727
[TBL] [Abstract][Full Text] [Related]
2. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.
Zhang Y; Toh L; Lau P; Wang X
J Biol Chem; 2012 Sep; 287(39):32494-511. PubMed ID: 22854964
[TBL] [Abstract][Full Text] [Related]
3. Tcf3 and cell cycle factors contribute to butyrate resistance in colorectal cancer cells.
Chiaro C; Lazarova DL; Bordonaro M
Biochem Biophys Res Commun; 2012 Nov; 428(1):121-6. PubMed ID: 23063976
[TBL] [Abstract][Full Text] [Related]
4. Henryin, an ent-kaurane diterpenoid, inhibits Wnt signaling through interference with β-catenin/TCF4 interaction in colorectal cancer cells.
Li X; Pu J; Jiang S; Su J; Kong L; Mao B; Sun H; Li Y
PLoS One; 2013; 8(7):e68525. PubMed ID: 23844215
[TBL] [Abstract][Full Text] [Related]
5. The lncRNA CRNDE promotes colorectal cancer cell proliferation and chemoresistance via miR-181a-5p-mediated regulation of Wnt/β-catenin signaling.
Han P; Li JW; Zhang BM; Lv JC; Li YM; Gu XY; Yu ZW; Jia YH; Bai XF; Li L; Liu YL; Cui BB
Mol Cancer; 2017 Jan; 16(1):9. PubMed ID: 28086904
[TBL] [Abstract][Full Text] [Related]
6. Attenuation of the beta-catenin/TCF4 complex in colorectal cancer cells induces several growth-suppressive microRNAs that target cancer promoting genes.
Schepeler T; Holm A; Halvey P; Nordentoft I; Lamy P; Riising EM; Christensen LL; Thorsen K; Liebler DC; Helin K; Ørntoft TF; Andersen CL
Oncogene; 2012 May; 31(22):2750-60. PubMed ID: 21963845
[TBL] [Abstract][Full Text] [Related]
7. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
[TBL] [Abstract][Full Text] [Related]
8. OVOL2, an Inhibitor of WNT Signaling, Reduces Invasive Activities of Human and Mouse Cancer Cells and Is Down-regulated in Human Colorectal Tumors.
Ye GD; Sun GB; Jiao P; Chen C; Liu QF; Huang XL; Zhang R; Cai WY; Li SN; Wu JF; Liu YJ; Wu RS; Xie YY; Chan EC; Liou YC; Li BA
Gastroenterology; 2016 Mar; 150(3):659-671.e16. PubMed ID: 26619963
[TBL] [Abstract][Full Text] [Related]
9. CREB-binding protein, p300, butyrate, and Wnt signaling in colorectal cancer.
Bordonaro M; Lazarova DL
World J Gastroenterol; 2015 Jul; 21(27):8238-48. PubMed ID: 26217075
[TBL] [Abstract][Full Text] [Related]
10. Pharmacological and genetic modulation of Wnt-targeted Cre-Lox-mediated gene expression in colorectal cancer cells.
Bordonaro M; Lazarova DL; Sartorelli AC
Nucleic Acids Res; 2004; 32(8):2660-74. PubMed ID: 15141037
[TBL] [Abstract][Full Text] [Related]
11. ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression.
Sánchez-Tilló E; de Barrios O; Valls E; Darling DS; Castells A; Postigo A
Oncogene; 2015 Nov; 34(46):5760-70. PubMed ID: 26387539
[TBL] [Abstract][Full Text] [Related]
12. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
13. Modulation of Wnt-specific colon cancer cell kill by butyrate and lithium.
Bordonaro M; Lazarova DL; Carbone R; Sartorelli AC
Oncol Res; 2004; 14(9):427-38. PubMed ID: 15490974
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the Wnt/B-catenin/TCF4 pathway using SAGE, genome-wide microarray and promoter analysis: Identification of BRI3 and HSF2 as novel targets.
Kavak E; Najafov A; Ozturk N; Seker T; Cavusoglu K; Aslan T; Duru AD; Saygili T; Hoxhaj G; Hiz MC; Unal DO; Birgül-Iyison N; Ozturk M; Koman A
Cell Signal; 2010 Oct; 22(10):1523-35. PubMed ID: 20538055
[TBL] [Abstract][Full Text] [Related]
15. Wnt/β-catenin signaling regulates Yes-associated protein (YAP) gene expression in colorectal carcinoma cells.
Konsavage WM; Kyler SL; Rennoll SA; Jin G; Yochum GS
J Biol Chem; 2012 Apr; 287(15):11730-9. PubMed ID: 22337891
[TBL] [Abstract][Full Text] [Related]
16. Linear relationship between Wnt activity levels and apoptosis in colorectal carcinoma cells exposed to butyrate.
Lazarova DL; Bordonaro M; Carbone R; Sartorelli AC
Int J Cancer; 2004 Jul; 110(4):523-31. PubMed ID: 15122584
[TBL] [Abstract][Full Text] [Related]
17. Thymine DNA glycosylase is a positive regulator of Wnt signaling in colorectal cancer.
Xu X; Yu T; Shi J; Chen X; Zhang W; Lin T; Liu Z; Wang Y; Zeng Z; Wang C; Li M; Liu C
J Biol Chem; 2014 Mar; 289(13):8881-90. PubMed ID: 24532795
[TBL] [Abstract][Full Text] [Related]
18. A novel ent-kaurane diterpenoid executes antitumor function in colorectal cancer cells by inhibiting Wnt/β-catenin signaling.
Ye Q; Yao G; Zhang M; Guo G; Hu Y; Jiang J; Cheng L; Shi J; Li H; Zhang Y; Liu H
Carcinogenesis; 2015 Mar; 36(3):318-26. PubMed ID: 25600769
[TBL] [Abstract][Full Text] [Related]
19. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
[TBL] [Abstract][Full Text] [Related]
20. SOX9 drives WNT pathway activation in prostate cancer.
Ma F; Ye H; He HH; Gerrin SJ; Chen S; Tanenbaum BA; Cai C; Sowalsky AG; He L; Wang H; Balk SP; Yuan X
J Clin Invest; 2016 May; 126(5):1745-58. PubMed ID: 27043282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
